Live feed16:05:00·29dPRReleaseMinerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026NERV· Minerva Neurosciences IncHealth CareOriginal source
